Related Experiment Video

Updated: May 22, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

Polyphenols counteract tumor cell chemoresistance conferred by multidrug resistance proteins

Krystyna Michalak1, Olga Wesolowska

  • 1Wrocław Medical University, Department of Biophysics, ul. Chałubińskiego 10, 50-368 Wrocław, Poland. michalak@biofiz.am.wroc.pl

Anti-Cancer Agents in Medicinal Chemistry
|May 16, 2012
PubMed

Insights

Plant-derived polyphenols can reverse cancer drug resistance by modulating ATP-binding cassette (ABC) multidrug transporters. These compounds show promise for overcoming chemotherapy resistance in clinical trials.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Cancer multidrug resistance is often mediated by ATP-binding cassette (ABC) transporters.
  • These transporters efflux anticancer drugs from cancer cells, reducing treatment efficacy.
  • Polyphenolic compounds from plants, such as flavonoids and stilbenes, are being investigated for their potential to overcome this resistance.

Purpose of the Study:

  • To review recent advances in understanding polyphenol interactions with ABC multidrug transporters.
  • To discuss the mechanisms by which flavonoids modulate these transporters.
  • To explore the structure-activity relationships of polyphenols in reversing multidrug resistance.

Main Methods:

  • Literature review of recent studies on polyphenol-ABC transporter interactions.
  • Analysis of in vitro data from resistant cancer cell lines.
  • Discussion of mechanistic insights and structure-activity relationships.

Main Results:

  • Numerous plant-derived polyphenols and their synthetic derivatives demonstrate the ability to reverse drug resistance in vitro.
  • Specific polyphenols modulate key ABC transporters like P-glycoprotein, MRP1, and BCRP.
  • Understanding the interaction mechanisms and structure-activity relationships is crucial for developing new therapies.

Conclusions:

  • Polyphenols represent a promising class of compounds for overcoming cancer multidrug resistance.
  • Further clinical trials are warranted to evaluate the therapeutic potential of identified polyphenolic compounds.
  • Targeting ABC transporters with polyphenols offers a viable strategy to enhance chemotherapy effectiveness.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...